← Browse by Condition
Medical Condition
dyslipidaemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 2, Phase 3
NCT07218900 Phase 2
Recruiting
A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia
Enrollment
76 pts
Location
Russia
Sponsor
AstraZeneca
NCT06834932 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
Enrollment
360 pts
Location
China, Hong Kong
Sponsor
AstraZeneca